208 related articles for article (PubMed ID: 8318410)
21. Isolation and properties of cell lines from the metastasising rat mammary tumour SMT-2A.
Rudland PS; Dunnington DJ; Kim U; Gusterson BA; O'Hare MJ; Monaghan P
Br J Cancer; 1989 Jun; 59(6):854-64. PubMed ID: 2736223
[TBL] [Abstract][Full Text] [Related]
22. Variability of tumor response to chemotherapy. I. Contribution of host heterogeneity.
Simpson-Herren L; Noker PE; Wagoner SD
Cancer Chemother Pharmacol; 1987; 20(4):297-304. PubMed ID: 3690803
[TBL] [Abstract][Full Text] [Related]
23. Characterization of metastatic heterogeneity among subpopulations of a single mouse mammary tumor: heterogeneity in phenotypic stability.
Miller FR; Miller BE; Heppner GH
Invasion Metastasis; 1983; 3(1):22-31. PubMed ID: 6677618
[TBL] [Abstract][Full Text] [Related]
24. [Relationship between sensitivity of tumor cells to chemotherapeutic agent in vivo and in vitro: experiment with mouse lymphoma cells].
Li CG; Li ML; Shu XH; Jia YJ; Liu YJ; Li M
Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(22):1576-8. PubMed ID: 17785116
[TBL] [Abstract][Full Text] [Related]
25. Heterogeneity in drug sensitivity among tumor cell subpopulations of a single mammary tumor.
Heppner GH; Dexter DL; DeNucci T; Miller FR; Calabresi P
Cancer Res; 1978 Nov; 38(11 Pt 1):3758-63. PubMed ID: 698935
[TBL] [Abstract][Full Text] [Related]
26. Development of drug resistance in a murine mammary tumour.
McMillan TJ; Stephens TC; Steel GG
Br J Cancer; 1985 Dec; 52(6):823-32. PubMed ID: 4074637
[TBL] [Abstract][Full Text] [Related]
27. Use of drug resistance markers to recover clonogenic tumor cells from occult metastases in host tissues.
Miller FR; McInerney DJ; Rogers C; Aitken DR; Wei WZ
Invasion Metastasis; 1986; 6(4):197-208. PubMed ID: 3759360
[TBL] [Abstract][Full Text] [Related]
28. Clones with different metastatic capacity and variant selection during metastasis: a problematic relationship.
Nanni P; De Giovanni C; Lollini PL; Nicoletti G; Prodi G
J Natl Cancer Inst; 1986 Jan; 76(1):87-93. PubMed ID: 3455746
[TBL] [Abstract][Full Text] [Related]
29. Generation of phenotypic diversity in the B16 mouse melanoma relative to spontaneous metastasis.
Stackpole CW
Cancer Res; 1983 Jul; 43(7):3057-65. PubMed ID: 6850615
[TBL] [Abstract][Full Text] [Related]
30. Combined treatment with verapamil, a calcium channel blocker, and B428, a synthetic uPA inhibitor, impairs the metastatic ability of a murine mammary carcinoma.
Todaro LB; Ladeda V; Bal de Kier Joffé E; Farías EF
Oncol Rep; 2003; 10(3):725-32. PubMed ID: 12684650
[TBL] [Abstract][Full Text] [Related]
31. Growth of rat mammary adenocarcinoma cells in semisolid clonogenic medium not correlated with spontaneous metastatic behavior: heterogeneity in the metastatic, antigenic, enzymatic, and drug sensitivity properties of cells from different sized colonies.
Nicolson GL; Lembo TM; Welch DR
Cancer Res; 1988 Jan; 48(2):399-404. PubMed ID: 2825974
[TBL] [Abstract][Full Text] [Related]
32. Potentiation of melphalan by systemic hyperthermia in mice: therapeutic gain for mouse lung microtumours.
Honess DJ; Bleehen NM
Int J Hyperthermia; 1985; 1(1):57-68. PubMed ID: 3837082
[TBL] [Abstract][Full Text] [Related]
33. Radioimmunotherapy of micrometastases in lung with vascular targeted 213Bi.
Kennel SJ; Boll R; Stabin M; Schuller HM; Mirzadeh S
Br J Cancer; 1999 Apr; 80(1-2):175-84. PubMed ID: 10389994
[TBL] [Abstract][Full Text] [Related]
34. Treatment with a non-steroidal anti-inflammatory agent delays the growth of spontaneous pulmonary metastases of a mammary adenocarcinoma of non-detected immunogenicity.
Fontán PA; Amura CR; Sordelli DO
Br J Cancer; 1992 Nov; 66(5):800-4. PubMed ID: 1419623
[TBL] [Abstract][Full Text] [Related]
35. Cyclocreatine in cancer chemotherapy.
Teicher BA; Menon K; Northey D; Liu J; Kufe DW; Kaddurah-Daouk R
Cancer Chemother Pharmacol; 1995; 35(5):411-6. PubMed ID: 7850923
[TBL] [Abstract][Full Text] [Related]
36. Warfarin inhibits metastasis of Mtln3 rat mammary carcinoma without affecting primary tumour growth.
McCulloch P; George WD
Br J Cancer; 1989 Feb; 59(2):179-83. PubMed ID: 2930682
[TBL] [Abstract][Full Text] [Related]
37. Effect of host immune status on the spontaneous metastasis of cloned cell lines of the 13762NF rat mammary adenocarcinoma.
North SM; Nicolson GL
Br J Cancer; 1985 Nov; 52(5):747-55. PubMed ID: 4063149
[TBL] [Abstract][Full Text] [Related]
38. Host immune potentiation of drug responses to a murine mammary adenocarcinoma. II. Effect of melphalan therapy on the host immune system.
Radov LA; Korn JH; Haskill JS
Int J Cancer; 1976 Nov; 18(5):630-8. PubMed ID: 992900
[TBL] [Abstract][Full Text] [Related]
39. In vitro comparative studies of the myelotoxicity and antitumor activity of 6-[bis-(2-chloroethyl)-amino]-6-deoxy-D-glucose versus melphalan utilizing the CFU-C and HTSCA assays.
Lazarus P; Dufour M; Isabel G; Panasci LC
Cancer Chemother Pharmacol; 1986; 16(2):148-52. PubMed ID: 3948300
[TBL] [Abstract][Full Text] [Related]
40. Emergence of nitrosourea resistant sublines of Lewis lung tumour following MeCCNU treatment in vivo.
Stephens TC; Adams K; Peacock JH
Br J Cancer; 1986 Feb; 53(2):237-45. PubMed ID: 3954945
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
